-+ 0.00%
-+ 0.00%
-+ 0.00%

Biogen To Highlight Translational RNAseq Findings And Preservation Of Humoral Immunity In Felzartamab-Treated IgA Nephropathy Patients

Benzinga·11/03/2025 12:38:19
Listen to the news
  • Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease modifying potential
  • Exhibitor Spotlight to discuss role of CD38 cells across a range of immune-mediated kidney diseases
  • Felzartamab, an investigational anti-CD38 monoclonal antibody, is a potentially differentiated therapeutic candidate with promise for a broad range of immune-mediated diseases